rs1799963

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 8P and 6B. PP5_Very_StrongBP4BS1_SupportingBS2

The NM_000506.5(F2):​c.*97G>A variant causes a splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0114 in 1,480,018 control chromosomes in the GnomAD database, including 136 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic low penetrance,risk factor (★★).

Frequency

Genomes: 𝑓 0.0096 ( 18 hom., cov: 32)
Exomes 𝑓: 0.012 ( 118 hom. )

Consequence

F2
NM_000506.5 splice_region

Scores

2

Clinical Significance

Pathogenic/Likely pathogenic/Pathogenic, low penetrance; risk factor criteria provided, multiple submitters, no conflicts P:23U:1O:6

Conservation

PhyloP100: 0.878

Publications

3468 publications found
Variant links:
Genes affected
F2 (HGNC:3535): (coagulation factor II, thrombin) This gene encodes the prothrombin protein (also known as coagulation factor II). This protein is proteolytically cleaved in multiple steps to form the activated serine protease thrombin. The activated thrombin enzyme plays an important role in thrombosis and hemostasis by converting fibrinogen to fibrin during blood clot formation, by stimulating platelet aggregation, and by activating additional coagulation factors. Thrombin also plays a role in cell proliferation, tissue repair, and angiogenesis as well as maintaining vascular integrity during development and postnatal life. Peptides derived from the C-terminus of this protein have antimicrobial activity against E. coli and P. aeruginosa. Mutations in this gene lead to various forms of thrombosis and dysprothrombinemia. Rapid increases in cytokine levels following coronavirus infections can dysregulate the coagulation cascade and produce thrombosis, compromised blood supply, and organ failure. [provided by RefSeq, May 2020]
F2 Gene-Disease associations (from GenCC):
  • thrombophilia due to thrombin defect
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • congenital prothrombin deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP5
Variant 11-46739505-G-A is Pathogenic according to our data. Variant chr11-46739505-G-A is described in ClinVar as Pathogenic/Likely_pathogenic/Pathogenic,_low_penetrance|risk_factor. ClinVar VariationId is 13310.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00957 (1457/152304) while in subpopulation AMR AF = 0.0151 (231/15296). AF 95% confidence interval is 0.0135. There are 18 homozygotes in GnomAd4. There are 666 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 18 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000506.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F2
NM_000506.5
MANE Select
c.*97G>A
splice_region
Exon 14 of 14NP_000497.1
F2
NM_000506.5
MANE Select
c.*97G>A
3_prime_UTR
Exon 14 of 14NP_000497.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F2
ENST00000311907.10
TSL:1 MANE Select
c.*97G>A
splice_region
Exon 14 of 14ENSP00000308541.5
F2
ENST00000311907.10
TSL:1 MANE Select
c.*97G>A
3_prime_UTR
Exon 14 of 14ENSP00000308541.5
F2
ENST00000862118.1
c.*97G>A
splice_region
Exon 14 of 14ENSP00000532177.1

Frequencies

GnomAD3 genomes
AF:
0.00957
AC:
1456
AN:
152186
Hom.:
18
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00234
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0151
Gnomad ASJ
AF:
0.0291
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00518
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0136
Gnomad OTH
AF:
0.0163
GnomAD4 exome
AF:
0.0116
AC:
15393
AN:
1327714
Hom.:
118
Cov.:
19
AF XY:
0.0114
AC XY:
7614
AN XY:
666466
show subpopulations
African (AFR)
AF:
0.00215
AC:
67
AN:
31094
American (AMR)
AF:
0.0102
AC:
440
AN:
43198
Ashkenazi Jewish (ASJ)
AF:
0.0358
AC:
900
AN:
25144
East Asian (EAS)
AF:
0.0000513
AC:
2
AN:
39002
South Asian (SAS)
AF:
0.00203
AC:
167
AN:
82360
European-Finnish (FIN)
AF:
0.00488
AC:
215
AN:
44064
Middle Eastern (MID)
AF:
0.0170
AC:
67
AN:
3944
European-Non Finnish (NFE)
AF:
0.0129
AC:
12888
AN:
1002874
Other (OTH)
AF:
0.0115
AC:
647
AN:
56034
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
764
1528
2293
3057
3821
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00957
AC:
1457
AN:
152304
Hom.:
18
Cov.:
32
AF XY:
0.00894
AC XY:
666
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00236
AC:
98
AN:
41574
American (AMR)
AF:
0.0151
AC:
231
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
101
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4820
European-Finnish (FIN)
AF:
0.00518
AC:
55
AN:
10616
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0136
AC:
923
AN:
68024
Other (OTH)
AF:
0.0161
AC:
34
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
82
163
245
326
408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0119
Hom.:
26
Bravo
AF:
0.0105
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Pathogenic/Likely pathogenic/Pathogenic, low penetrance; risk factor
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
11
-
-
Thrombophilia due to thrombin defect (12)
7
-
-
not provided (7)
3
-
-
Congenital prothrombin deficiency (4)
1
-
-
Congenital prothrombin deficiency;C0948008:Ischemic stroke;C3160733:Thrombophilia due to thrombin defect;C3280672:Pregnancy loss, recurrent, susceptibility to, 2 (1)
-
1
-
Pregnancy loss, recurrent, susceptibility to, 2 (2)
-
-
-
Cerebral palsy (1)
-
-
-
Ischemic stroke (1)
-
-
-
Thrombophilia caused by F2 prothrombin deficiency (1)
-
-
-
Venous thromboembolism (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
8.1
DANN
Benign
0.76
PhyloP100
0.88
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799963; hg19: chr11-46761055; API